Yes, but the dose required is 35 higher than sublingual or intranasal routes to achieve comparable plasma concentrations
For instance, nanoparticle-based inhalers have been shown to increase lung deposition of medications by up to 3.68 times more compared to traditional inhalers, potentially revolutionizing the treatment of conditions like cystic fibrosis and severe asthma
Product Specifications + Product: GHK-Cu (Copper Tripeptide-1) CAS Number: 89030-95-5 Classification: Tripeptidecopper(II) complex Sequence: Glycyl-L-Histidyl-L-Lysine (Gly-His-Lys) bound to Cu Form: Lyophilised blue/blue-violet powder Purity: 99% (HPLC/MS verified) Available Strengths: 50mg, 100mg Vial Size: 3ml Solubility: Reconstitutable with bacteriostatic water Storage: Cool, dry, protected from light Third-Party Testing: Janoshik Analytical reports available Intended Use: Laboratory research only Why Bangkok Peptides 99% Purity HPLC/MS verified purity standards across every batch produced under controlled laboratory conditions
However, no significant difference was recorded in serum levels of bicarbonate, sodium, uric acid, or total protein in the treated group (TG) compared with the positive control (PC) ( Figure 1 )
30-60 minutes: The average onset time for both medications to start working
